The company and the board of directors confirm that the information contained herein is true, accurate, complete, and free from any false records, misleading statements, or major omissions.
300026SZSE
Announcement on Completing the Supplementary Election of the Company's Ninth Board of Directors Independent Director
✨ AI Summary
Tianjin Chase Sun Pharmaceutical Co., Ltd. held its ninth board of directors meeting to elect a supplementary independent director. Mr. [blank] was unanimously approved to serve until May 20, 2025. This election ensures the company complies with legal requirements for independent director representation on the board.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.